Hematopoietic SH2 Domain Containing (HSH2D) Peptide
-
- Target See all HSH2D products
- HSH2D (Hematopoietic SH2 Domain Containing (HSH2D))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- DPCVATSLKS PSQPQAPKDR KVPTRKAERS VSCIEVTPGD RSWHQMVVRA
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of HSH2 D antibody,
Alternative Names: HSH2D control peptide, HSH2D antibody Blocking Peptide, Anti-HSH2D Blocking Peptide, hematopoietic SH2 domain containing Blocking Peptide, ALX Blocking Peptide, FLJ14886 Blocking Peptide, HSH2 Blocking Peptide, HSH2D, HSHD-2, HSHD 2, HSHD-2 Blocking Peptide, HSHD 2 Blocking Peptide - Purification
- The antibody was purified from rabbit antiserum by affinity-chromatography using epitope-specific phosphopeptide and cross-adsorbed with the corresponding non-phosphopeptide.
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- HSH2D (Hematopoietic SH2 Domain Containing (HSH2D))
- Background
- T-cell activation requires 2 signals: recognition of antigen by the T-cell receptor and a costimulatory signal provided primarily by CD28 in naive T cells. HSH2 is a target of both of these signaling pathways.
- Molecular Weight
- 39 kDa
-